Case C-74/03
Fecha: 16-Sep-2004
The Directive 5.At the material time, the relevant rules were primarily contained in Chapter II of the Directive as amended, in particular, by Directive 87/21/EEC.(5) Article 3 of the Directive provided that, in the absence of a Community-wide authorisation, a medicinal product could be marketed in a Member State only after authorisation had been o...